Infections in Women’s Health

At Labassure, we offer specialized diagnostic tests to accurately detect and manage infections affecting women’s reproductive and gynecologic health. These often asymptomatic or subtle infections can lead to serious complications such as infertility, recurrent miscarriage, chronic pelvic pain, ectopic pregnancy, and adverse pregnancy outcomes like preterm labor or implantation failure.

Timely detection is essential to prevent progression and guide treatment. Our diagnostics use high-sensitivity molecular methods, including PCR-based assays, on samples such as endometrial tissue, vaginal or cervical swabs, urine, or blood—depending on clinical needs. These tests support care in gynecology, infertility, and reproductive medicine settings.

‍

The Pelvic Inflammatory Disease (PID) Panel screens for key upper genital tract pathogens like Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Ureaplasma species—common causes of pelvic infections that may lead to scarring and tubal infertility. The Sexually Transmitted Infections (STI) Panel provides broad screening for high-risk viral and bacterial infections, including HSV, HPV, Trichomonas vaginalis, Mycoplasma hominis, and Ureaplasma urealyticum, which can impact reproductive health if left undetected.

Genital tuberculosis testing is another critical component of our offering, especially in regions where TB is endemic. Genital TB is a known cause of tubal factor infertility and implantation failure. Labassure provides TB-PCR, acid-fast bacilli (AFB) smear, and culture for detection from endometrial tissue, urine, or semen samples.

Additionally, our Chronic Endometritis Panel helps diagnose persistent inflammation of the endometrial lining using CD138 immunohistochemistry, histology, and molecular identification of potential pathogens—supporting improved fertility outcomes in women with recurrent implantation failure or thin endometrium.

By integrating advanced diagnostics with clinical precision, Labassure helps clinicians uncover hidden infections that impact reproductive health—enabling early intervention, targeted treatment, and improved outcomes for fertility and pregnancy care

‍

Our Infection portfolio integrates:

Sexually Transmitted Disease Panel

The STD Panel uses multiplex PCR to detect high-risk and co-infective organisms that may contribute to gynecologic infections, infertility, and poor pregnancy outcomes. The test includes screening for both bacterial and viral STIs.

Key Benefits:

High Sensitivity & Specificity: Molecular detection ensures accurate diagnosis, even in asymptomatic cases
Multi-Pathogen Detection: Screens for Chlamydia, Gonorrhea, Trichomonas, Mycoplasma, Ureaplasma, HSV 1/2, and high-risk HPV
Prevents Complications: Early treatment reduces the risk of PID, miscarriage, or transmission
Ideal for Routine Screening: Especially important in fertility assessments and pregnancy planning
Supports Partner Management: Timely identification enables effective contact tracing and treatment
‍

Recommended For:
‍

All sexually active women
Preconception and IVF patients
Women with abnormal Pap smear results
Recurrent vaginal infections or discharge

Pelvic Inflammatory Disease Panel

The PID Panel screens for a range of sexually transmitted and opportunistic infections responsible for Pelvic Inflammatory Disease, a major cause of infertility, ectopic pregnancy, and chronic pelvic pain in women. The panel includes high-sensitivity molecular tests for multiple pathogens commonly involved in pelvic infections.

Key Benefits:

Comprehensive Coverage: Detects major causative organisms including Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Ureaplasma species
Fertility-Focused: Helps prevent long-term reproductive complications through early detection
Molecular Precision: Real-time PCR ensures high accuracy and low false positives
Enables Targeted Therapy: Results support pathogen-specific treatment and better outcomes
Applicable in Acute & Chronic Cases: Useful in both symptomatic PID and unexplained infertility

Recommended For:
‍

Women with chronic pelvic pain or abnormal discharge
Patients undergoing infertility workup
Suspected or confirmed pelvic infections
Cases with tubal factor infertility

Chronic Endometritis Panel

Chronic endometritis (CE) is an often-silent condition that may impair implantation, contribute to recurrent miscarriage, or affect endometrial receptivity. Labassure’s CE panel combines histopathology, immunohistochemistry (CD138), and PCR-based pathogen detection to provide a complete diagnostic picture.

Key Benefits:

High Diagnostic Accuracy: Combines morphological and molecular evaluation
Detects Plasma Cell Infiltration: CD138 IHC is the gold standard marker
Identifies Underlying Infection: Includes PCR for Mycoplasma, Ureaplasma, and Chlamydia
Improves IVF Outcomes: Treatment of CE enhances implantation rates and pregnancy success
Actionable Reports: Supports antibiotic planning and repeat biopsy monitoring

Recommended For:
‍

Women with recurrent implantation failure (RIF) or miscarriage
Thin endometrium or unresponsive endometrial lining
Chronic spotting or abnormal uterine bleeding
Suspected post-infectious endometrial changes

Chronic Endometritis Panel

‍

Key Benefits:

High Diagnostic Accuracy: Combines morphological and molecular evaluation
Detects Plasma Cell Infiltration: CD138 IHC is the gold standard marker
Identifies Underlying Infection: Includes PCR for Mycoplasma, Ureaplasma, and Chlamydia
Improves IVF Outcomes: Treatment of CE enhances implantation rates and pregnancy success
Actionable Reports: Supports antibiotic planning and repeat biopsy monitoring

Recommended For:

Women with recurrent implantation failure (RIF) or miscarriage
Thin endometrium or unresponsive endometrial lining
Chronic spotting or abnormal uterine bleeding
Suspected post-infectious endometrial changes

‍

Infections in Women’s Health

Corporate

Test & Services

Infections in Women’s Health

STD Panel (CT,NG,MG,TV,HSV1&2,CV,UU,UP)

STD Extended Panel (CT,NG,MG,TV,HSV1&2,CV,UU,UP,MH,CA,TP)

Pelvic Inflammatory Disease PID (CT,NG, MG, TV)

Mycobacterium Tuberculosis (MTB) DNA PCR

NMT/MTB (MOTT) PCR

MTB PCR for Tissue Sample

MTB MDR Drug Resistance PCR

Chronic Endometritis (CE) Panel - NG,CT,EF,EC,SAg,SAu,MG,MH,UU

CE Panel with MTB

Corporate

Test & Services